Ovid Therapeutics Inc (OVID)
3.07
+0.08
(+2.68%)
USD |
NASDAQ |
Apr 26, 13:24
Ovid Therapeutics Revenue (TTM): 0.3917M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.3917M |
September 30, 2023 | 0.2964M |
Date | Value |
---|---|
June 30, 2023 | 0.1985M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.1985M
Minimum
Jun 2023
0.3917M
Maximum
Dec 2023
0.2955M
Average
0.2964M
Median
Sep 2023
Revenue (TTM) Benchmarks
Ligand Pharmaceuticals Inc | 131.31M |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 7.098M |
iBio Inc | -- |
Theriva Biologics Inc | -- |